Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Bone Marrow Transplantation, Published online: 25 September 2023; doi:10.1038/s41409-023-02110-4Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Source: Bone Marrow Transplantation - September 25, 2023 Category: Hematology Authors: Gabrielle Meyers Mehdi Hamadani Michael Martens Haris Ali Patrice Chevallier Hannah Choe Andrew C. Harris Ernst Holler Eric van Hooren Willem Klaassen Eric Leifer Ypke van Oosterhout Lia Perez Iskra Pusic Matthias Stelljes Walter van der Velden Emanuele A Source Type: research